A model-based approach to investigate the effect of elevated interstitial fluid pressure on strain elastography

A Novel Poroelastography Method for High-Quality Estimation of Lateral Strain, Solid Stress, and Fluid Pressure In Vivo

Assessment of mechanical and transport properties of tissues using ultrasound elasticity imaging requires accurate estimations of the spatiotemporal distribution of volumetric strain. Due to physical constraints such as pitch limitation and the lack of phase information in the lateral direction, the quality of lateral strain estimation is typically significantly lower than the quality of axial strain estimation. In this paper, a novel lateral strain estimation technique based on the physics of compressible porous media is developed, tested and validated. This technique is referred to as "Poroelastography-based Ultrasound Lateral Strain Estimation" (PULSE). PULSE differs from previously proposed lateral strain estimators as it uses the underlying physics of internal fluid flow within a local region of the tissue as theoretical foundation. PULSE establishes a relation between spatiotemporal changes in the axial strains and corresponding spatiotemporal changes in the lateral strains, effectively allowing assessment of lateral strains with comparable quality of axial strain estimators. We demonstrate that PULSE can also be used to accurately track compression-induced solid stresses and fluid pressure in cancers using ultrasound poroelastography (USPE). In this study, we report the theoretical formulation for PULSE and validation using finite element (FE) and ultrasound simulations. PULSE-generated results exhibit less than 5% percentage relative error (PRE) and greater than 90% structural similarity index (SSIM) compared to ground truth simulations. Experimental results are included to qualitatively assess the performance of PULSE in vivo. The proposed method can be used to overcome the inherent limitations of non-axial strain imaging and improve clinical translatability of USPE.

Assessing Therapeutic Nanoparticle Accumulation in Tumors Using Nanobubble-Based Contrast-Enhanced Ultrasound Imaging

This study explores the challenges associated with nanoparticle-based drug delivery to the tumor parenchyma, focusing on the widely utilized enhanced permeability and retention effect (EPR). While EPR has been a key strategy, its inconsistent clinical success lacks clear mechanistic understanding and is hindered by limited tools for studying relevant phenomena. This work introduces an approach that employs multiparametric dynamic contrast-enhanced ultrasound (CEUS) with a nanoscale contrast agent for noninvasive, real-time examination of tumor microenvironment characteristics. We demonstrate that CEUS imaging can: (1) evaluate tumor microenvironment features, (2) be used to help predict the distribution of doxorubicin-loaded liposomes in the tumor parenchyma, and (3) be used to predict nanotherapeutic efficacy. CEUS using nanobubbles (NBs) was carried out in two tumor types of high (LS174T) and low (U87) vascular permeability. LS174T tumors consistently showed significantly different time intensity curve (TIC) parameters, including area under the rising curve (AUCR, 2.7×) and time to peak intensity (TTP, 1.9×) compared to U87 tumors. Crucially, a recently developed decorrelation time (DT) parameter specific to NB CEUS dynamics successfully predicted the distribution of doxorubicin-loaded liposomes within the tumor parenchyma (r = 0.86 ± 0.13). AUCR, TTP, and DT were used to correlate imaging findings to nanotherapeutic response with 100% accuracy in SKOV-3 tumors. These findings suggest that NB-CEUS parameters can effectively discern tumor vascular permeability, serving as a biomarker for identifying tumor characteristics and predicting the responsiveness to nanoparticle-based therapies. The observed differences between LS174T and U87 tumors and the accurate prediction of nanotherapeutic efficacy in SKOV-3 tumors indicate the potential utility of this method in predicting treatment efficacy and evaluating EPR in diseases characterized by pathologically permeable vasculature. Ultimately, this research contributes valuable insights into refining drug delivery strategies and assessing the broader applicability of EPR-based approaches.

Characterization of Indeterminate Breast Lesions Based on Pressure Estimates by Noninvasive 3D Contrast-Enhanced Ultrasound

OBJECTIVE

To assess the ability of the pressure gradient between breast lesions and adjacent normal tissue estimated by 3D subharmonic-aided pressure estimation (SHAPE) to characterize indeterminate breast lesions.

METHODS

This prospective study enrolled patients scheduled for ultrasound-guided needle biopsies of a breast lesion. Before the biopsy, 3D SHAPE data were collected from the breast lesion during the infusion of an ultrasound contrast agent (Definity) as well as after clearance of the agent. Direct, invasive pressure measurements in the lesion and adjacent normal tissue were then obtained using an intracompartmental pressure monitoring system (C2DX) before tissue sampling as part of the biopsy procedure. The mean SHAPE gradient and invasive measurement gradient between the lesion and adjacent normal tissue were compared to the biopsy results. The SHAPE gradients were also compared to the invasive pressure gradients.

RESULTS

There were 8 malignant and 13 benign lesions studied. The SHAPE gradients and invasive pressure gradients were significantly different between the benign and malignant lesions (2.86 ± 3.24 vs. -0.03 ± 1.72 a.u.; p = 0.03 and 9.9 ± 8.5 vs. 20.9 ± 8.0 mmHg; p = 0.008, respectively). The area under the curves, specificities, and sensitivities for detecting malignancy by SHAPE gradients and invasive pressure gradients were 0.79 and 0.88, 77% and 92%, and 88% and 50%, respectively. A weak negative correlation was found between the SHAPE and invasive pressure gradients (r = -0.2).

CONCLUSION

The pressure gradient between a breast lesion and adjacent normal tissue estimated by 3D SHAPE shows potential for characterizing indeterminate breast lesions.

Effect of interstitial fluid pressure on shear wave elastography: an experimental and computational study

Objective. An elevated interstitial fluid pressure (IFP) can lead to strain-induced stiffening of poroelastic biological tissues. As shear wave elastography (SWE) measures functional tissue stiffness based on the propagation speed of acoustically induced shear waves, the shear wave velocity (SWV) can be used as an indirect measurement of the IFP. The underlying biomechanical principle for this stiffening behavior with pressurization is however not well understood, and we therefore studied how IFP affects SWV through SWE experiments and numerical modeling.Approach. For model set-up and verification, SWE experiments were performed while dynamically modulating IFP in a chicken breast. To identify the confounding factors of the SWV-IFP relationship, we manipulated the material model (linear poroelastic versus porohyperelastic), deformation assumptions (geometric linearity versus nonlinearity), and boundary conditions (constrained versus unconstrained) in a finite element model mimicking the SWE experiments.Main results. The experiments demonstrated a statistically significant positive correlation between the SWV and IFP. The model was able to reproduce a similar SWV-IFP relationship by considering an unconstrained porohyperelastic tissue. Material nonlinearity was identified as the primary factor contributing to this relationship, whereas geometric nonlinearity played a smaller role. The experiments also highlighted the importance of the dynamic nature of the pressurization procedure, as indicated by a different observed SWV-IFP for pressure buildup and relaxation, but its clinical relevance needs to be further investigated.Significance. The developed model provides an adaptable framework for SWE of poroelastic tissues and paves the way towards non-invasive measurements of IFP.

Using imaging modalities to predict nanoparticle distribution and treatment efficacy in solid tumors: The growing role of ultrasound

Nanomedicine in oncology has not had the success in clinical impact that was anticipated in the early stages of the field's development. Ideally, nanomedicines selectively accumulate in tumor tissue and reduce systemic side effects compared to traditional chemotherapeutics. However, this has been more successful in preclinical animal models than in humans. The causes of this failure to translate may be related to the intra- and inter-patient heterogeneity of the tumor microenvironment. Predicting whether a patient will respond positively to treatment prior to its initiation, through evaluation of characteristics like nanoparticle extravasation and retention potential in the tumor, may be a way to improve nanomedicine success rate. While there are many potential strategies to accomplish this, prediction and patient stratification via noninvasive medical imaging may be the most efficient and specific strategy. There have been some preclinical and clinical advances in this area using MRI, CT, PET, and other modalities. An alternative approach that has not been studied as extensively is biomedical ultrasound, including techniques such as multiparametric contrast-enhanced ultrasound (mpCEUS), doppler, elastography, and super-resolution processing. Ultrasound is safe, inexpensive, noninvasive, and capable of imaging the entire tumor with high temporal and spatial resolution. In this work, we summarize the in vivo imaging tools that have been used to predict nanoparticle distribution and treatment efficacy in oncology. We emphasize ultrasound imaging and the recent developments in the field concerning CEUS. The successful implementation of an imaging strategy for prediction of nanoparticle accumulation in tumors could lead to increased clinical translation of nanomedicines, and subsequently, improved patient outcomes. This article is categorized under: Diagnostic Tools In Vivo Nanodiagnostics and Imaging Therapeutic Approaches and Drug Discovery Nanomedicine for Oncologic Disease Therapeutic Approaches and Drug Discovery Emerging Technologies.

Assessing Tumor Microenvironment Characteristics and Stratifying EPR with a Nanobubble Companion Nanoparticle via Contrast-Enhanced Ultrasound Imaging

The tumor microenvironment is characterized by dysfunctional endothelial cells, resulting in heightened vascular permeability. Many nanoparticle-based drug delivery systems attempt to use this enhanced permeability combined with impaired lymphatic drainage (a concept known as the 'enhanced permeability and retention effect' or EPR effect) as the primary strategy for drug delivery, but this has not proven to be as clinically effective as anticipated. The specific mechanisms behind the inconsistent clinical outcomes of nanotherapeutics have not been clearly articulated, and the field has been hampered by a lack of accessible tools to study EPR-associated phenomena in clinically relevant scenarios. While medical imaging has tremendous potential to contribute to this area, it has not been broadly explored. This work examines, for the first time, the use of multiparametric dynamic contrast-enhanced ultrasound (CEUS) with a novel nanoscale contrast agent to examine tumor microenvironment characteristics noninvasively and in real-time. We demonstrate that CEUS imaging can: (1) evaluate tumor microenvironment features and (2) be used to help predict the distribution of doxorubicin-loaded liposomes in the tumor parenchyma. CEUS using nanobubbles (NBs) was carried out in two tumor types of high (LS174T) and low (U87) vascular permeability, and time-intensity curve (TIC) parameters were evaluated in both models prior to injection of doxorubicin liposomes. Consistently, LS174T tumors showed significantly different TIC parameters, including area under the rising curve (2.7x), time to peak intensity (1.9x) and decorrelation time (DT, 1.9x) compared to U87 tumors. Importantly, the DT parameter successfully predicted tumoral nanoparticle distribution (r = 0.86 ± 0.13). Ultimately, substantial differences in NB-CEUS generated parameters between LS174T and U87 tumors suggest that this method may be useful in determining tumor vascular permeability and could be used as a biomarker for identifying tumor characteristics and predicting sensitivity to nanoparticle-based therapies. These findings could ultimately be applied to predicting treatment efficacy and to evaluating EPR in other diseases with pathologically permeable vasculature.

Noninvasive ultrasound assessment of tissue internal pressure using dual mode elasticity imaging: a phantom study

Objective.Tissue internal pressure, such as interstitial fluid pressure in solid tumors and intramuscular pressure in compartment syndrome, is closely related to the pathological state of tissues. It is of great diagnostic value to measure and/or monitor the internal pressure of targeted tissues. Because most of the current methods for measuring tissue pressure are invasive, noninvasive methods are highly desired. In this study, we developed a noninvasive method for qualitative assessment of tissue internal pressure based on a combination of two ultrasound elasticity imaging methods: strain imaging and shear wave elasticity imaging.Approach.The method was verified through experimental investigation using two tissue-mimicking phantoms each having an inclusion confined by a membrane, in which hydrostatic pressures can be applied and maintained. To examine the sensitivity of the elasticity imaging methods to pressure variation, strain ratio and shear modulus ratio (SMR) between the inclusion and background of phantom were obtained.Main results.The results first experimentally prove that pressure, in addition to elasticity, is a contrast mechanism of strain imaging, and further demonstrate that a comparative analysis of strain ratio and SMR is an effective method for noninvasive tissue internal pressure detection.Significance.This work provides a new perspective in interpreting the strain ratio data in medical diagnosis, and it also provides a noninvasive alternative for assessing tissue internal pressure, which could be valuable for the diagnosis of pressure-related diseases.

Interstitial fluid pressure as an emerging biomarker in solid tumors

The physical microenvironment of cancer is characterized by elevated stiffness and tissue pressure, the main component of which is the interstitial fluid pressure (IFP). Elevated IFP is an established negative predictive and prognostic parameter, directly affecting malignant behavior and therapy response. As such, measurement of the IFP would allow to develop strategies aimed at engineering the physical microenvironment of cancer. Traditionally, IFP measurement required the use of invasive methods. Recent progress in dynamic and functional imaging methods such as dynamic contrast enhanced (DCE) magnetic resonance imaging and elastography, combined with numerical models and simulation, allows to comprehensively assess the biomechanical landscape of cancer, and may help to overcome physical barriers to drug delivery and immune cell infiltration. Here, we provide a comprehensive overview of the origin of elevated IFP, and its role in the malignant phenotype. Also, we review the methods used to measure IFP using invasive and imaging based methods, and highlight remaining obstacles and potential areas of progress in order to implement IFP measurement in clinical practice.

A digital viscoelastic liver phantom for investigation of elastographic measurements

To develop elastography imaging technologies and implement image reconstruction algorithms, testing is done with phantoms. Although the validation step is usually taken using real data and physical phantoms, their geometry as well as composition, biomechanical parameters, and details of applying stress cannot be modified readily. Such considerations have gained increasing importance with the growth of elastography techniques as one of the non-invasive medical imaging modalities, which can map the elastic properties and stiffness of soft tissues. In this article, we develop a digital viscoelastic phantom using computed tomography (CT) imaging data and several application software tools based on illustrations of normal liver anatomy so as to investigate the biomechanics of elastography via finite element modeling (FEM). Here we discuss how to create this phantom step by step, demonstrate typical shear wave elastography (SWE) experiments of applying transient stress to the liver model, and calculate quantitative measurements. In particular, shear wave velocities are investigated through a parametric study designed based on tissue stiffness and distance from the applied stress. According to the results of FEM analysis, low errors were obtained for shear wave velocity estimation for both mechanical stress (~2-5%) and acoustic radiation force (~3-7%). Results show that our model is a powerful framework and benchmark for simulating and implementing different algorithms in shear wave elastography, which can serve as a guide for upcoming researches and assist scientists to optimize their subsequent experiments in terms of design.

A Spline Interpolation-based Data Reconstruction Technique for Estimation of Strain Time Constant in Ultrasound Poroelastography

Ultrasound poroelastography is a cost-effective and noninvasive imaging technique, which can be used to reconstruct mechanical parameters of tissues such as Young's modulus, Poisson's ratio, interstitial permeability, and vascular permeability. To estimate interstitial permeability and vascular permeability using poroelastography, accurate estimation of the strain time constant (TC) is required. This can be a challenging task due to the nonlinearity of the exponential strain curve and noise affecting the experimental data. Due to motion artifacts caused by the sonographer, animal/patient, and/or the environment, noise affecting some strain frames can be significantly higher than the strain signal. If these frames are used for the computation of the strain TC, the resulting TC estimate can be highly inaccurate, which, in turn, can cause high errors in the reconstructed mechanical parameters. In this paper, we introduce a cubic spline-based interpolation method, which allows to use only good quality strain frames (i.e., frames with sufficiently high signal-to-noise ratio [SNR]) to estimate the strain TC. Using finite element simulations, we demonstrate that the proposed interpolation method can improve the estimation accuracy of the strain TC by 46% with respect to the case where no interpolation and filtering are used and by 37% with respect to the case where the strain frames are Kalman filtered before TC estimation (at an SNR of 30 dB). We also prove the technical feasibility of the proposed technique using in vivo experimental data. While detecting the bad frames in both simulations and experiments, we assumed the lower limit SNR to be below 10 dB. Based on our results, the proposed technique may be of great help in applications relying on the accurate assessment of the temporal behavior of strain data.

Non-Invasive Imaging of Normalized Solid Stress in Cancers in Vivo

The solid stress (SSg) that develops inside a cancer is an important marker of cancer’s growth, invasion and metastasis. Currently, there are no non-invasive methods to image SSg inside tumors. In this paper, we develop a new, non-invasive and cost-effective imaging method to assess SSg inside tumors that uses ultrasound poroelastography. Center to the proposed method is a novel analytical model, which demonstrates that SSg and the compression-induced stress (SSc) that generates inside the cancer in a poroelastography experiment have the same spatial distribution. To show the clinical feasibility of the proposed technique, we imaged and analyzed the normalized SSg inside treated and untreated human breast cancers in a small animal model. Given the clinical significance of assessing SSg in cancers and the advantages of the proposed ultrasonic methods, our technique could have a great impact on cancer diagnosis, prognosis and treatment methods.